Evaluation of bone marrow-derived mesenchymal stem cell quality from patients with congenital pseudoarthrosis of the tibia.
Ismail Hadisoebroto DilogoFajar MujadidRetno Wahyu NurhayatiAryadi KurniawanPublished in: Journal of orthopaedic surgery and research (2018)
MSC quality is not the main reason for delayed bone regeneration in those with CPT. Thus, autologous MSC is a promising source for treating CPT patients.